Concepedia

Author

Sven Schmiedl

Witten/Herdecke UniversityORCID

Also Known As

F. Schmidt, M. Rottenkolber , Michaela Duck, P. Thürmann, S Schmiedl, S. Schmiedl, S. Schmiedl , Schmiedl, S., Schmiedl, Sven, Sven Schmiedl

86

Publications

2.2K

Citations

17

H-Index

47

Concepts

All Affiliations

Witten/Herdecke UniversityHelios Universitätsklinikum WuppertalLudwig-Maximilians-Universität MünchenUtrecht UniversityAgencia Española de Medicamentos y Productos Sanitarios
SS

About

Sven Schmiedl is an author at Witten/Herdecke University specializing in medicine, pharmacoepidemiology, and patient safety.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

450

2

Public Health

2

2

56

3

Cell Biology

1

1

10

4

Epidemiology

1

1

48

5

Gastroenterology

1

1

11

Sven Schmiedl

×

25

Publications

1.1K

Citations

15

H-Index

YearCitations

Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations

Dominik Rottenkolber, Sven Schmiedl, Marietta Rottenkolber,

Pharmacoepidemiology and Drug Safety

2011

160

Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications

Victoria Abbing‐Karahagopian, Consuelo Huerta, Patrick C. Souverein,

European Journal of Clinical Pharmacology

2014

158

Self-Medication with Over-the-Counter and Prescribed Drugs Causing Adverse-Drug-Reaction-Related Hospital Admissions: Results of a Prospective, Long-Term Multi-Centre Study

Sven Schmiedl, Marietta Rottenkolber, Joerg Hasford,

Drug Safety

2014

133

Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU Project

Consuelo Huerta, Victoria Abbing‐Karahagopian, Gema Requena,

Pharmacoepidemiology and Drug Safety

2015

130

Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national drug utilization study

Luisa Ibáñez, Mònica Sabaté, Xavier Vidal,

British Journal of Clinical Pharmacology

2019

54

Prevalence of antibiotic use: a comparison across various European health care data sources

Ruth Brauer, Ana Ruigómez, Gerry Downey,

Pharmacoepidemiology and Drug Safety

2015

53

A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events

Jean‐Luc Faillie, Pili Ferrer, Amandine Gouverneur,

Journal of Clinical Epidemiology

2017

48

Preventable ADRs leading to hospitalization — results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients

Sven Schmiedl, Marietta Rottenkolber, Jacek Szymański,

Expert Opinion on Drug Safety

2017

48

Incidence Rates and Trends of Hip/Femur Fractures in Five European Countries: Comparison Using E-Healthcare Records Databases

Gema Requena, Victoria Abbing‐Karahagopian, Consuelo Huerta,

Calcified Tissue International

2014

43

Antiepileptic drug use in seven electronic health record databases in <scp>E</scp>urope: A methodologic comparison

Mark de Groot, Markus Schuerch, Frank de Vries,

Epilepsia

2014

38

Page 1